Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

2 terminated/withdrawn out of 10 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT04323787Completed

Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry

Role: collaborator

NCT06207201Completed

Discover In-Hospital Cardiac Arrest

Role: collaborator

NCT03539783Completed

Identifying PARDS Endotypes

Role: collaborator

NCT04977297Not ApplicableCompleted

Move to Music Video Intervention for ICU Survivors

Role: collaborator

NCT04249141Withdrawn

Determinants of Implementation Success Coordinating Ventilator, Early Ambulation and Rehabilitation Efforts

Role: collaborator

NCT04486521Unknown

Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19

Role: collaborator

NCT03513289Completed

Collaborative Assessment of ICU Recovery Needs

Role: collaborator

NCT00798590Phase 2Terminated

The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients

Role: collaborator

NCT00542321Not ApplicableCompleted

Pilot Study of Lateral Rotation Interventions for Efficacy and Safety in ICU Care

Role: collaborator

NCT00129077Not ApplicableCompleted

Does the Use of a Moisture Chamber Decrease the Incidence of Corneal Abrasions in Critically Ill Pediatric Patients?

Role: collaborator

All 10 trials loaded